CD44 and cancer: The conclusion of the bioprinted model of breast cancer–vessel–bone architecture represents a significant advancement in tissue engineering, with functional blood vessels expressing crucial markers like endothelial vascular CD31, cancer stem cell CD44, and osteogenic OCN.